Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Colon Cancer Stage 4”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02460198
What this trial is testing

Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Previously-Treated Locally Advanced Unresectable or Metastatic Colorectal Cancer (MK-3475-164/KEYNOTE-164)

Who this might be right for
Colorectal Carcinoma
Merck Sharp & Dohme LLC 124
Testing effectiveness (Phase 2)Study completedNCT00080834
What this trial is testing

DJ-927 as Second-Line Therapy in Treating Patients With Progressive Locally Advanced or Metastatic Colorectal Adenocarcinoma

Who this might be right for
Colorectal Cancer
Daiichi Sankyo
Testing effectiveness (Phase 2)Active Not RecruitingNCT04895722
What this trial is testing

Evaluation of Co-formulated Pembrolizumab/Quavonlimab (MK-1308A) Versus Other Treatments in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Cancer (CRC) (MK-1308A-008/KEYSTEP-008).

Who this might be right for
Colorectal Cancer
Merck Sharp & Dohme LLC 302
Post-approval studies (Phase 4)Looking for participantsNCT06562543
What this trial is testing

A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer

Who this might be right for
Colorectal Cancer
Takeda 78
Testing effectiveness (Phase 2)Active Not RecruitingNCT04644068
What this trial is testing

Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies

Who this might be right for
Ovarian CancerBreast CancerPancreatic Cancer+10 more
AstraZeneca 702
Not applicableStudy completedNCT02305368
What this trial is testing

Evaluation of Interest Chemo-oncogramme in Patients With Colonic Adenocarcinoma Stage 4

Who this might be right for
Colon Cancer
University Hospital, Limoges 20
Not applicableWithdrawnNCT01199250
What this trial is testing

Biomarkers in Samples From Patients With Endometrial Cancer

Who this might be right for
Lynch SyndromeRecurrent Uterine Corpus CarcinomaStage I Uterine Corpus Cancer+3 more
Gynecologic Oncology Group
Early research (Phase 1)Ended earlyNCT03275974
What this trial is testing

Glutamine PET Imaging Colorectal Cancer

Who this might be right for
RAS Wild TypeStage IV Colorectal CancerStage IVA Colorectal Cancer+1 more
M.D. Anderson Cancer Center 6
Not applicableStudy completedNCT06326619
What this trial is testing

Survival Benefit of Primary Tumour Resection Compared to Systemic Therapy Alone in Stage IV Colorectal Cancer Patients

Who this might be right for
Colorectal CancerNeoadjuvant Systemic Therapy
Medizinische Hochschule Brandenburg Theodor Fontane 480
Not applicableNot Yet RecruitingNCT06879886
What this trial is testing

MRD-Guided Surveillance in Resectable Stage IV Metastatic Colorectal Cancer (SURVEILLANCE-II)

Who this might be right for
Colorectal Cancer (CRC)Colorectal Cancer Liver Metastases (CRLM)
Fudan University 181
Early research (Phase 1)Study completedNCT03849469
What this trial is testing

XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors

Who this might be right for
MelanomaCervical CarcinomaPancreatic Carcinoma+20 more
Xencor, Inc. 78
Testing effectiveness (Phase 2)Study completedNCT00557102
What this trial is testing

Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver and/or Lung

Who this might be right for
Colorectal CancerMetastatic Cancer
National Cancer Institute, France 24
Early research (Phase 1)Study completedNCT00535353
What this trial is testing

AZD2281 and Irinotecan in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
NCIC Clinical Trials Group 26
Large-scale testing (Phase 3)Study completedNCT00265824
What this trial is testing

Optimized Chemotherapy Followed by Maintenance With Bevacizumab With or Without Erlotinib in Treating Patients With Metastatic Colorectal Cancer That Cannot be Removed by Surgery (DREAM)

Who this might be right for
Colorectal Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 700
Early research (Phase 1)Ended earlyNCT05631574
What this trial is testing

Study of Covalent Menin Inhibitor BMF-219 in Adult Patients With KRAS Driven Non-Small Cell Lung Cancer, Pancreatic Cancer, and Colorectal Cancer

Who this might be right for
Non Small Cell Lung CancerPancreatic CancerColorectal Cancer+14 more
Biomea Fusion Inc. 13
Large-scale testing (Phase 3)Study completedNCT00975897
What this trial is testing

Study of Tumor Tissue Testing in Selecting Treatment for Patients With Metastatic or Locally Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Medical Research Council 3,240
Early research (Phase 1)Study completedNCT00280176
What this trial is testing

Bortezomib, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Rectal Cancer

Who this might be right for
Colorectal Cancer
UNC Lineberger Comprehensive Cancer Center 11
Early research (Phase 1)Looking for participantsNCT06336902
What this trial is testing

Botensilimab Plus Balstilimab and Fasting Mimicking Diet Plus Vitamin C for Patients With KRAS-Mutant Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal AdenocarcinomaStage IV Colorectal Cancer AJCC v8
University of Southern California 15
Testing effectiveness (Phase 2)Study completedNCT00003995
What this trial is testing

Monoclonal Antibody Plus Chemotherapy in Treating Patients With Advanced Colorectal Cancer That Overexpresses HER2

Who this might be right for
Colorectal Cancer
National Cancer Institute (NCI) 32
Testing effectiveness (Phase 2)Study completedNCT00016250
What this trial is testing

Ro 31-7453 in Treating Patients With Recurrent or Refractory Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Memorial Sloan Kettering Cancer Center
Next Page